AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29701554 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsurgical clipping of ruptured MCA aneurysms
Number of subjects: 46
Study 28139830 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (100 mg/day for 7 days)
Number of subjects: 40
Study 25888250 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 5,000 IU/dose, subcutaneously administered at 48 hours and 72 hours after acute IS
Number of subjects: 142
Study 25888250 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 142
Study 25888250 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study 23751884 — intervention group
Group type: EXPERIMENTAL
Intervention: Hassle Free Mealtimes Triple P
Number of subjects: 96
Study 23751884 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 96
Study 21749851 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary pancreatic duct stent (5F diameter, 3 cm long, straight with unflanged inner end)
Number of subjects: 426
Study 21749851 — intervention group
Group type: COMPARATOR
Intervention: No pancreatic duct stent (control group)
Number of subjects: 426
Study 21749851 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary pancreatic duct stent
Number of subjects: 426
Study 21749851 — intervention group
Group type: COMPARATOR
Intervention: No pancreatic duct stent
Number of subjects: 426
Study 19178948 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (20 Hz, 110% of MT, 20 trains, 10 s intertrain interval)
Number of subjects: 41
Study 19178948 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 41
Study 16719606 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention
Number of subjects: 250
Study 16719606 — intervention group
Group type: EXPERIMENTAL
Intervention: Education plus group discussion intervention
Number of subjects: 250
Study 16719606 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 250
Study 15278105 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary Weight Loss
Number of subjects: 316
Study 15278105 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet+Exercise
Number of subjects: 316
Study 15278105 — intervention group
Group type: COMPARATOR
Intervention: Exercise Training
Number of subjects: 316
Study 15278105 — intervention group
Group type: COMPARATOR
Intervention: Healthy Lifestyle Controls
Number of subjects: 316
Study 11297242 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT (2 x 100 mg capsules) and leucovorin (2 x 15 mg tablets) administered after an overnight fast
Number of subjects: 25
Study 11297242 — intervention group
Group type: COMPARATOR
Intervention: UFT (2 x 100 mg capsules) and leucovorin (2 x 15 mg tablets) administered 5 min after a high‐fat meal
Number of subjects: 25
Study 9702571 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable thermometers
Number of subjects: 26350
Study 9702571 — intervention group
Group type: COMPARATOR
Intervention: Electronic thermometers
Number of subjects: 26350
Study 8018355 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast neutron radiotherapy
Number of subjects: 0
Study 8018355 — intervention group
Group type: COMPARATOR
Intervention: Photon/electron radiation
Number of subjects: 0
Study 2791759 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomifensine
Number of subjects: 40
Study 2791759 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 40
Study 55583 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer factor (T.F.) prepared from 5 x 10(8) lymphoid cells from 500 ml of a parent's blood
Number of subjects: 40
Study 55583 — intervention group
Group type: COMPARATOR
Intervention: Control group of 35 similar children
Number of subjects: 40
Study 31770207 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.3 μg/kg/h)
Number of subjects: 44
Study 31770207 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 44
Study 27837014 — intervention group
Group type: EXPERIMENTAL
Intervention: Zombie pandemic theme
Number of subjects: 89
Study 27837014 — intervention group
Group type: COMPARATOR
Intervention: Natural disaster scenario
Number of subjects: 89
Study 26021662 — intervention group
Group type: EXPERIMENTAL
Intervention: Full threaded, cannulated compression screws (Acutrak 6/7, ACUMED)
Number of subjects: 44
Study 26021662 — intervention group
Group type: COMPARATOR
Intervention: Partial threaded, 6.5mm or 7.3mm cannulated screws (SYNTHES)
Number of subjects: 44
Study 23890471 — intervention group
Group type: EXPERIMENTAL
Intervention: Paleolithic diet
Number of subjects: 13
Study 23890471 — intervention group
Group type: COMPARATOR
Intervention: Diabetes diet
Number of subjects: 13
Study 21223501 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-BF+active
Number of subjects: 36
Study 21223501 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-BF
Number of subjects: 36
Study 21223501 — intervention group
Group type: COMPARATOR
Intervention: WL control
Number of subjects: 36
Study 19147365 — intervention group
Group type: COMPARATOR
Intervention: WBV-exercise on a stable platform (VibM; n=17, mean age 61.5+/‐9.2)
Number of subjects: 52
Study 19147365 — intervention group
Group type: COMPARATOR
Intervention: WBV-exercise on a balance board (VibF; n=18, mean age 58.7+/‐11.0)
Number of subjects: 52
Study 19147365 — intervention group
Group type: COMPARATOR
Intervention: Control group (Con; n=18, mean age 61.1+/‐8.5)
Number of subjects: 52
Study 17350369 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive culture results (n = 40)
Number of subjects: 54
Study 17350369 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative culture results (n = 14)
Number of subjects: 54
Study 17350369 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of IABP support
Number of subjects: 54
Study 17350369 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of multiple central catheters
Number of subjects: 54
Study 15154945 — intervention group
Group type: EXPERIMENTAL
Intervention: Staged Diabetes Management (SDM) programme
Number of subjects: 340
Study 15154945 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 340
Study 11569481 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (4.6 g n-3 fatty acids/day)
Number of subjects: 29
Study 11569481 — intervention group
Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 29
Study 9259247 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pamidronate (APD), 300 mg/day plus calcium 1 g/day
Number of subjects: 60
Study 9259247 — intervention group
Group type: COMPARATOR
Intervention: Calcium alone
Number of subjects: 60
Study 9259247 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pamidronate (APD)
Number of subjects: 60
Study 9259247 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 60
Study 8512628 — intervention group
Group type: EXPERIMENTAL
Intervention: Milacemide 400 mg/day
Number of subjects: 148
Study 8512628 — intervention group
Group type: EXPERIMENTAL
Intervention: Milacemide 800 mg/day
Number of subjects: 148
Study 8512628 — intervention group
Group type: EXPERIMENTAL
Intervention: Milacemide 1200 mg/day
Number of subjects: 148
Study 8512628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 8512628 — intervention group
Group type: EXPERIMENTAL
Intervention: Milacemide (all doses combined)
Number of subjects: 148
Study 3325320 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron protein succinylate
Number of subjects: 40
Study 3325320 — intervention group
Group type: COMPARATOR
Intervention: Iron sulphate
Number of subjects: 40
Study 29133161 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) with Ropivacaine, 150 ml
Number of subjects: 40
Study 29133161 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution), 150 ml
Number of subjects: 40
Study 26781394 — intervention group
Group type: EXPERIMENTAL
Intervention: SPS with alcohol and povidone‐iodine before draping and an additional SPS by iodine povacrylex and isopropyl alcohol before application of the final adhesive drape
Number of subjects: 600
Study 25495747 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary Care Triple P (n = 34)
Number of subjects: 67
Study 25495747 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (n = 33)
Number of subjects: 67
Study 22809024 — intervention group
Group type: EXPERIMENTAL
Intervention: Resuscitating acupuncture
Number of subjects: 290
Study 22809024 — intervention group
Group type: COMPARATOR
Intervention: Sham-acupoints
Number of subjects: 290
Study 20132152 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg/day irsogladine maleate (n = 150)
Number of subjects: 322
Study 20132152 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 161)
Number of subjects: 322
Study 18753647 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib plus melphalan and prednisone
Number of subjects: 682
Study 18753647 — intervention group
Group type: COMPARATOR
Intervention: Melphalan and prednisone alone (control group)
Number of subjects: 682
Study 15929750 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 14527077 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical nasal corticosteroids for 8 weeks
Number of subjects: 28
Study 14527077 — intervention group
Group type: COMPARATOR
Intervention: Placebo saline spray for 8 weeks
Number of subjects: 28
Study 14527077 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical nasal corticosteroids for 4 weeks followed by placebo saline spray for 4 weeks
Number of subjects: 28
Study 14527077 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo saline spray for 4 weeks followed by topical nasal corticosteroids for 4 weeks
Number of subjects: 28
Study 10559704 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 10
Study 10559704 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 10
Study 10559704 — intervention group
Group type: EXPERIMENTAL
Intervention: Tianeptine
Number of subjects: 10
Study 10559704 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 10
Study 8742912 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (5 mg, long acting slow release oral)
Number of subjects: 30
Study 8742912 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 1444726 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 97
Study 1444726 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone and supportive therapy
Number of subjects: 97
Study 1444726 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone and coping skills therapy
Number of subjects: 97
Study 1444726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 4056254 — intervention group
Group type: EXPERIMENTAL
Intervention: Theobromine (10 mg/kg)
Number of subjects: 0
Study 4056254 — intervention group
Group type: COMPARATOR
Intervention: Theophylline (5 mg/kg)
Number of subjects: 0
Study 4056254 — intervention group
Group type: EXPERIMENTAL
Intervention: Theobromine and Theophylline
Number of subjects: 0
Study 31058705 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation intervention
Number of subjects: 95
Study 31058705 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 95
Study 29791287 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 493
Study 29791287 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy (anthracycline and taxane) without bevacizumab
Number of subjects: 493
Study 29791287 — intervention group
Group type: EXPERIMENTAL
Intervention: pCR status
Number of subjects: 493
Study 27098821 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention website
Number of subjects: 3044
Study 25710011 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical stabilization using Stracos
Number of subjects: 20
Study 25710011 — intervention group
Group type: COMPARATOR
Intervention: Control group (conservative management)
Number of subjects: 20
Study 24252648 — intervention group
Group type: COMPARATOR
Intervention: Standard implementation strategy (Replicating Effective Programs, or REP)
Number of subjects: 158
Study 24252648 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced REP with External Facilitation
Number of subjects: 158
Study 20429895 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga plus Cognitive Behavioral Therapy (CBT) smoking cessation intervention
Number of subjects: 0
Study 20429895 — intervention group
Group type: COMPARATOR
Intervention: Wellness program plus Cognitive Behavioral Therapy (CBT) smoking cessation intervention
Number of subjects: 0
Study 18835425 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's disease group
Number of subjects: 18
Study 18835425 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study 16620718 — intervention group
Group type: EXPERIMENTAL
Intervention: CEUS (contrast-enhanced ultrasound)
Number of subjects: 211
Study 16620718 — intervention group
Group type: COMPARATOR
Intervention: US (routine ultrasound)
Number of subjects: 211
Study 12944689 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythrocyte GSH levels in AMI patients
Number of subjects: 22
Study 12944689 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 22
Study 12944689 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cholesterol and triglycerides in AMI patients
Number of subjects: 22
Study 10795592 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.9 Lf tetanus toxoid (0.25 ml)
Number of subjects: 200
Study 10795592 — intervention group
Group type: COMPARATOR
Intervention: 3.75 Lf tetanus toxoid (0.5 ml)
Number of subjects: 200
Study 10795592 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (1.9 Lf and 3.75 Lf)
Number of subjects: 200
Study 8846172 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 56
Study 8846172 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 56
Study 8846172 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prognosis for the whole group
Number of subjects: 56
Study 1538359 — intervention group
Group type: EXPERIMENTAL
Intervention: Count-to-10 method
Number of subjects: 85
Study 1538359 — intervention group
Group type: COMPARATOR
Intervention: Other charting methods
Number of subjects: 85
Study 6502941 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (900 mg, p.o. daily)
Number of subjects: 12
Study 31107327 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedicle guider technology
Number of subjects: 32
Study 31107327 — intervention group
Group type: COMPARATOR
Intervention: Freehand technique (Control)
Number of subjects: 32
Study 29625340 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin
Number of subjects: 125
Study 29625340 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 125
Study 29625340 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 125
Study 29625340 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 125
Study 29625340 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 125
Study 29625340 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline
Number of subjects: 125
Study 27020037 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRP-2 test
Number of subjects: 47
Study 27020037 — intervention group
Group type: COMPARATOR
Intervention: Insulin tolerance test (ITT)
Number of subjects: 47
Study 25088835 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrograde angioplasty (RAG)
Number of subjects: 96
Study 25088835 — intervention group
Group type: COMPARATOR
Intervention: Anterograde angioplasty (AAG)
Number of subjects: 96
Study 22560503 — intervention group
Group type: EXPERIMENTAL
Intervention: First trial feedback
Number of subjects: 0
Study 22560503 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance feedback
Number of subjects: 0
Study 22560503 — intervention group
Group type: COMPARATOR
Intervention: Stimulus cue presentation
Number of subjects: 0
Study 18837470 — intervention group
Group type: EXPERIMENTAL
Intervention: Pol + BG (5 g beta-glucan)
Number of subjects: 12
Study 18837470 — intervention group
Group type: COMPARATOR
Intervention: Pol (without beta-glucan)
Number of subjects: 12
Study 17200680 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer
Number of subjects: 127
Study 17200680 — intervention group
Group type: COMPARATOR
Intervention: Calcium-containing phosphate binders
Number of subjects: 127
Study 16084463 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg intrarectal lidocaine jelly
Number of subjects: 10
Study 16084463 — intervention group
Group type: COMPARATOR
Intervention: Saline jelly (placebo)
Number of subjects: 10
Study 12034124 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual force levels beyond 1.9 N/cm
Number of subjects: 6
Study 12034124 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual force levels from 0.76 to 4.54 N/cm
Number of subjects: 6
Study 10495407 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT
Number of subjects: 267
Study 10495407 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 267
Study 7598153 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupationally embedded exercise
Number of subjects: 52
Study 7598153 — intervention group
Group type: COMPARATOR
Intervention: Rote exercise
Number of subjects: 52
Study 1687485 — intervention group
Group type: EXPERIMENTAL
Intervention: Savoxepine (0.5 mg)
Number of subjects: 28
Study 1687485 — intervention group
Group type: COMPARATOR
Intervention: Chlorpromazine (75 mg)
Number of subjects: 28
Study 1687485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 1687485 — intervention group
Group type: EXPERIMENTAL
Intervention: Savoxepine (average 0.1 to 0.9 mg/d) in clinical trials
Number of subjects: 28
Study 6660442 — intervention group
Group type: EXPERIMENTAL
Intervention: scopolamine-TTS
Number of subjects: 100
Study 31791295 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine care plus WeChat breastfeeding education
Number of subjects: 0
Study 31791295 — intervention group
Group type: COMPARATOR
Intervention: Routine antenatal and postnatal care (Control)
Number of subjects: 0
Study 29478117 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior PECD combined with VAT
Number of subjects: 44
Study 29478117 — intervention group
Group type: COMPARATOR
Intervention: Conventional posterior PECD
Number of subjects: 44
Study 27769289 — intervention group
Group type: EXPERIMENTAL
Intervention: Oily fish consumption (300 g/week)
Number of subjects: 200
Study 27769289 — intervention group
Group type: COMPARATOR
Intervention: Poultry (control)
Number of subjects: 200
Study 25142075 — intervention group
Group type: EXPERIMENTAL
Intervention: Mistletoe extract treatment (subcutaneous injection, escalating doses, three times a week)
Number of subjects: 220
Study 25142075 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (control group)
Number of subjects: 220
Study 25142075 — intervention group
Group type: EXPERIMENTAL
Intervention: Mistletoe extract treatment
Number of subjects: 220
Study 23127448 — intervention group
Group type: EXPERIMENTAL
Intervention: Drainage treatment (group 1)
Number of subjects: 80
Study 23127448 — intervention group
Group type: COMPARATOR
Intervention: No drainage treatment (group 2)
Number of subjects: 80
Study 20567989 — intervention group
Group type: EXPERIMENTAL
Intervention: Keel technique
Number of subjects: 161
Study 20567989 — intervention group
Group type: EXPERIMENTAL
Intervention: Onlay technique
Number of subjects: 161
Study 20567989 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublay technique
Number of subjects: 161
Study 20567989 — intervention group
Group type: COMPARATOR
Intervention: General complications rate
Number of subjects: 161
Study 17980250 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD6140 90 mg
Number of subjects: 990
Study 17980250 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD6140 180 mg
Number of subjects: 990
Study 17980250 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 300 mg loading dose plus 75 mg once daily
Number of subjects: 990
Study 15745385 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled tiotropium bromide 18 microg
Number of subjects: 10
Study 15745385 — intervention group
Group type: COMPARATOR
Intervention: Inhaled Placebo
Number of subjects: 10
Study 12479050 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.2 mg daily for four weeks
Number of subjects: 43
Study 9469330 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative treatment with one course of fluorouracil, doxorubicin, and cyclophosphamide (FAC)
Number of subjects: 441
Study 9469330 — intervention group
Group type: COMPARATOR
Intervention: No further therapy (Control)
Number of subjects: 441
Study 9469330 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative treatment with one course of FAC
Number of subjects: 441
Study 7897053 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated participants
Number of subjects: 38
Study 7897053 — intervention group
Group type: COMPARATOR
Intervention: Untreated participants
Number of subjects: 38
Study 2472521 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCG 115 BS 5 mg p.o.
Number of subjects: 25
Study 2472521 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCG 115 BS 10 mg p.o.
Number of subjects: 25
Study 2472521 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous treatment with 10 mg UDCG 115 BS/day for greater than 5 days
Number of subjects: 25
Study 2472521 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine (optimal dose)
Number of subjects: 25
Study 438015 — intervention group
Group type: EXPERIMENTAL
Intervention: Eucapnic hyperventilation at body conditions (0 heat flux)
Number of subjects: 8
Study 438015 — intervention group
Group type: EXPERIMENTAL
Intervention: Eucapnic hyperventilation with decreased water content and temperature of the inspirate
Number of subjects: 8
Study 438015 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreasing thermal burden by reducing ventilation (VE)
Number of subjects: 8
Study 31894022 — intervention group
Group type: EXPERIMENTAL
Intervention: Human gamma globulin (HGG)
Number of subjects: 80
Study 31894022 — intervention group
Group type: COMPARATOR
Intervention: Control group (comprehensive treatment)
Number of subjects: 80